in effect
This is a presidential Executive Order (Executive Order 14228, signed March 3, 2025). It amends an earlier order (Executive Order 14195) that had placed tariffs on goods imported from China, using the President’s emergency economic powers to address fentanyl and other synthetic opioids coming from China into the United States.
The order makes one concrete change: it raises the tariff rate on products from China from 10 percent to 20 percent. The President states this is because China has not, in his determination, taken adequate steps to cooperate on stopping the flow of illicit drugs, and the crisis identified in the earlier order has not eased. It does this by striking the words “10 percent” in the original order and replacing them with “20 percent.” No new deadline, product list, or agency process is created — it only changes the rate. The tariffs apply to the same category of Chinese-origin goods defined by the earlier order and its related Federal Register notice.
U.S. importers of Chinese-made goods are directly affected, since they pay the higher 20 percent tariff at the border. That increased cost can flow through to businesses that rely on those imports and, potentially, to consumers. The order also states it creates no legal rights or benefits that any person or party can enforce in court against the U.S. government.